Ambry Genetics

Ambry Genetics As a company built by scientists, genetic counselors and physicians, Ambry, a Tempus company, is your partner in genetics and genomics.

As a company built by scientists, genetic counselors and physicians, we are your partner in genetics and genomics.

Today we celebrate International Day of Women and Girls in Science, a time to highlight female contributions in the fiel...
02/11/2026

Today we celebrate International Day of Women and Girls in Science, a time to highlight female contributions in the fields of science and technology. Ambry is proud to be lead by strong women in leadership positions and to be recognized as a Comparably Best Company for Women.

NEW WHITE PAPER:Ambry is proud to collaborate with the University of California, Irvine (UCI) and the Genomics Research ...
02/11/2026

NEW WHITE PAPER:
Ambry is proud to collaborate with the University of California, Irvine (UCI) and the Genomics Research to Elucidate the Genetics of Rare diseases (GREGoR) Consortium to support the Pediatric Mendelian Genomics Research Center (PMGRC) program. Together, we’re advancing the understanding of the biological mechanisms underlying rare diseases and supporting patient diagnosis with the latest genomic technologies.

Explore real case examples demonstrating how patients benefitted from long‑read whole genome sequencing and learn more about this collaborative effort:
https://hubs.ly/Q042tL2J0

Heather Rocha, MS, CGC, joins us in the Gene Scene to discuss pathogenic variants in LMNA, which are associated with mor...
02/10/2026

Heather Rocha, MS, CGC, joins us in the Gene Scene to discuss pathogenic variants in LMNA, which are associated with more than 10 distinct disorders with high clinical variability, referred to as the laminopathies. Dive deeper:
https://hubs.ly/Q042tMMz0

How does Ambry’s Classifi® program translate new evidence into actionable updates to our oncology test menu? Discover ho...
02/09/2026

How does Ambry’s Classifi® program translate new evidence into actionable updates to our oncology test menu? Discover how and dive deeper into case studies involving RPS20 and CTNNA1 in this white paper.
https://hubs.ly/Q042jk2R0

February is National Cancer Prevention Month, a time to explore how you can prevent cancer or take steps with your docto...
02/06/2026

February is National Cancer Prevention Month, a time to explore how you can prevent cancer or take steps with your doctor to detect it sooner. Ambry’s solutions help lower barriers for patients to access screening and genetic testing for hereditary cancer risk.

Standard exome tests can still leave families searching for answers . ExomeReveal™ changes that by integrating RNA analy...
02/05/2026

Standard exome tests can still leave families searching for answers . ExomeReveal™ changes that by integrating RNA analysis to confirm splicing variants, delivering more definitive results and reducing uncertainty.
This advanced approach increases the diagnostic yield of our exome by an additional 2-3%, contributing to an overall 20% relative increase in diagnostic power over standard exome tests when combined with our Patient for Life™ program. For clinicians and families navigating rare diseases, this means greater clarity and a clearer path forward.
Unlock more answers with ExomeReveal. https://hubs.ly/Q041-Dgc0

Ambry recognizes World Cancer Day. We are glad for this opportunity to share the importance of genetic testing in identi...
02/04/2026

Ambry recognizes World Cancer Day. We are glad for this opportunity to share the importance of genetic testing in identifying hereditary cancer risks and to work toward raising awareness, expanding research, and providing more equitable access to healthcare.

Welcome to our new series: Making Waves with MAVEs! Today, we’re excited to announce a new study published in Nature Com...
02/04/2026

Welcome to our new series: Making Waves with MAVEs!

Today, we’re excited to announce a new study published in Nature Communications, which builds on Ambry’s contributions to MAVE research by deepening the understanding of PALB2 and its role in hereditary cancer predisposition. 🌊 Read the press release here: https://hubs.ly/Q041PFsr0.

Plus, our new white paper reveals how MAVEs and our Ambry Classifi® program work together to generate and translate functional data for variant (re)classification—driving clarity for thousands of patients. 🌊Get the white paper here: https://hubs.ly/Q041PGXY0.

Caitlin Reid, MS, LGC, explores the BMPR1A gene and its connection to juvenile polyposis syndrome (JPS). JPS causes the ...
02/03/2026

Caitlin Reid, MS, LGC, explores the BMPR1A gene and its connection to juvenile polyposis syndrome (JPS). JPS causes the development of multiple "juvenile" polyps in the gastrointestinal tract, most commonly in the colon, but also in the stomach and small intestine. Dive deeper for clinical insights: https://hubs.ly/Q041nsh_0

This National Cancer Prevention Week, take charge of your health with informed choices and early action. Ambry empowers ...
02/02/2026

This National Cancer Prevention Week, take charge of your health with informed choices and early action. Ambry empowers you to understand your hereditary cancer risk through genetic testing.
Know your family history, talk to your doctor about regular screenings and genetic tests, and make healthy lifestyle choices. Share to spread awareness—prevention starts with knowledge.

02/02/2026

Ambry has been helping patients get access to testing with greater clarity by leveraging RNA since 2019. We are thrilled to announce that we have completed over 1,000,000 RNA analyses for patients!
Read the press release: https://hubs.ly/Q041jWjQ0

Are you a recent Genetic Counseling grad? We've helped hundreds study with our Genetic Counseling Boards Review. Join us...
01/30/2026

Are you a recent Genetic Counseling grad? We've helped hundreds study with our Genetic Counseling Boards Review. Join us for this trivia-style event. We have one more session on February 3. Register today:
https://hubs.ly/Q040W8y_0

Address

15 Argonaut
Aliso Viejo, CA
92656

Alerts

Be the first to know and let us send you an email when Ambry Genetics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category